Trial intelligence / Profile preview

Intranasal oxytocin during crack/cocaine detoxification

RBR-383vcpRecruiting

Sponsor
National Council for Scientific and Technological Development
Start
Nov 2016
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Randomised trial of oxytocin in cocaine use disorder (CUD) (2 arms), sponsored by National Council for Scientific and Technological Development. Primary endpoint: Functional MRI response during resting state and crack cue cognitive task. Started Nov 2016; status: recruiting.

02

Drugs

oxytocin
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on RBR-383vcp.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-383vcp.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call